GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology market and expanding its preventive healthcare through adult vaccines. With 30 crore prescriptions annually, GSK aims to innovate and grow its portfolio, highlighting price strategies catering to a broad market range, from general medicines to high-value therapies.
Related Posts
Airtel deal with Musk’s Starlink to bring high-speed net to India
- staff
- March 11, 2025
- 0
Airtel gains a competitive edge by entering a partnership with Elon Musk’s Starlink to market broadband and internet satellite services in India. This will enhance […]
Pixxel wins Nasa contract for hyperspectral Earth observation tech
Pixxel, a space startup based in Bengaluru, has been awarded a contract by Nasa as part of the $476 million Commercial SmallSat Data Acquisition Program. […]
‘DeepSeek DID NOT build OpenAI for USD 5M’ : Bernstein dismisses the Chinese company’s claims
- staff
- January 29, 2025
- 0
DeepSeek’s rapid rise on social media has sparked excitement and stock market reactions. However, Bernstein’s report reveals that DeepSeek’s claims about building an OpenAI equivalent […]